Tome
Gene Editing Biotech Tome Scales Back Operations Despite $213M Funding Round
Gene editing, biotech, Tome, funding, investor sentiment, layoffs, reorganization
Actionable Insights Powered by AI
Gene editing, biotech, Tome, funding, investor sentiment, layoffs, reorganization